Comparison of 21 artificial intelligence algorithms in automated diabetic retinopathy screening using handheld fundus camera

References

• Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi: 10.1016/j.diabres.2021.109119.
   PubMed Web of Science ®Google Scholar
• Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis. 2015;2:17.
   PubMedGoogle Scholar
• Teo ZL, Tham Y-C, Yu M, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021;128(11):1580–1591. doi: 10.1016/j.ophtha.2021.04.027.
   PubMed Web of Science ®Google Scholar
• Hautala N, Aikkila R, Korpelainen J, et al. Marked reductions in visual impairment due to diabetic retinopathy achieved by efficient screening and timely treatment. Acta Ophthalmol. 2014;92(6):582–587. doi: 10.1111/aos.12278.
   PubMed Web of Science ®Google Scholar
• Purola PKM, Ojamo MUI, Gissler M, et al. Changes in visual impairment due to diabetic retinopathy during 1980–2019 based on nationwide register data. Diabetes Care. 2022;45(9):2020–2027. doi: 10.2337/dc21-2369.
   PubMed Web of Science ®Google Scholar
• Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996;124(1 Pt 2):164–169. doi: 10.7326/0003-4819-124-1_part_2-199601011-00017.
   PubMed Web of Science ®Google Scholar
• Javitt JC, Aiello LP, Chiang Y, et al. Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care. 1994;17(8):909–917. doi: 10.2337/diacare.17.8.909.
   PubMed Web of Science ®Google Scholar
• Xie Y, Nguyen QD, Hamzah H, et al. Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling study. Lancet Digit Health. 2020;2(5):e240–e249. doi: 10.1016/S2589-7500(20)30060-1.
   PubMedGoogle Scholar
• Hautala N, Hyytinen P, Saarela V, et al. A mobile eye unit for screening of diabetic retinopathy and follow-up of glaucoma in remote locations in Northern Finland. Acta Ophthalmol. 2009;87(8):912–913. doi: 10.1111/j.1755-3768.2009.01570.x.
   PubMed Web of Science ®Google Scholar
• Summanen P, Kallioniemi V, Komulainen J, et al. Update on current care guideline: diabetic retinopathy. Duodecim. 2015;131(9):893–894.
   PubMedGoogle Scholar
• Cleland CR, Rwiza J, Evans JR, et al. Artificial intelligence for diabetic retinopathy in low-income and middle-income countries: a scoping review. BMJ Open Diabetes Res Care. 2023;11(4):e003424. doi: 10.1136/bmjdrc-2023-003424.
   PubMed Web of Science ®Google Scholar
• Whitestone N, Nkurikiye J, Patnaik JL, et al. Feasibility and acceptance of artificial intelligence-based diabetic retinopathy screening in Rwanda. Br J Ophthalmol. 2023. doi: 10.1136/bjo-2022-322683.
   Google Scholar
• Vujosevic S, Aldington SJ, Silva P, et al. Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol. 2020;8(4):337–347. doi: 10.1016/S2213-8587(19)30411-5.
   PubMed Web of Science ®Google Scholar
• Olvera-Barrios A, Heeren TF, Balaskas K, et al. Diagnostic accuracy of diabetic retinopathy grading by an artificial intelligence-enabled algorithm compared with a human standard for wide-field true-colour confocal scanning and standard digital retinal images. Br J Ophthalmol. 2021;105(2):265–270. doi: 10.1136/bjophthalmol-2019-315394.
   PubMed Web of Science ®Google Scholar
• Heydon P, Egan C, Bolter L, et al. Prospective evaluation of an artificial intelligence-enabled algorithm for automated diabetic retinopathy screening of 30 000 patients. Br J Ophthalmol. 2021;105(5):723–728. doi: 10.1136/bjophthalmol-2020-316594.
   PubMed Web of Science ®Google Scholar
• Lupidi M, Danieli L, Fruttini D, et al. Artificial intelligence in diabetic retinopathy screening: clinical assessment using handheld fundus camera in a real-life setting. Acta Diabetol. 2023;60(8):1083–1088. doi: 10.1007/s00592-023-02104-0.
   PubMed Web of Science ®Google Scholar
• Malerbi FK, Andrade RE, Morales PH, et al. Diabetic retinopathy screening using artificial intelligence and handheld smartphone-based retinal camera. J Diabetes Sci Technol. 2022;16(3):716–723. doi: 10.1177/1932296820985567.
   PubMedGoogle Scholar
• Kubin AM, Wirkkala J, Keskitalo A, et al. Handheld fundus camera performance, image quality and outcomes of diabetic retinopathy grading in a pilot screening study. Acta Ophthalmol. 2021;99(8):e1415–e1420.
   PubMed Web of Science ®Google Scholar
• Panwar N, Huang P, Lee J, et al. Fundus photography in the 21st century – a review of recent technological advances and their implications for worldwide healthcare. Telemed J E Health. 2016;22(3):198–208. doi: 10.1089/tmj.2015.0068.
   PubMed Web of Science ®Google Scholar
• Salongcay RP, Aquino LAC, Salva CMG, et al. Comparison of handheld retinal imaging with ETDRS 7-standard field photography for diabetic retinopathy and diabetic macular edema. Ophthalmol Retina. 2022;6(7):548–556. doi: 10.1016/j.oret.2022.03.002.
   PubMedGoogle Scholar
• Grzybowski A, Brona P. Analysis and comparison of two artificial intelligence diabetic retinopathy screening algorithms in a pilot study: IDx-DR and retinalyze. J Clin Med. 2021;10(11):2352. doi: 10.3390/jcm10112352.
   PubMed Web of Science ®Google Scholar
• van der Heijden AA, Abramoff MD, Verbraak F, et al. Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn diabetes care system. Acta Ophthalmol. 2018;96(1):63–68. doi: 10.1111/aos.13613.
   PubMed Web of Science ®Google Scholar
• Grzybowski A, Brona P, Lim G, et al. Artificial intelligence for diabetic retinopathy screening: a review. Eye. 2020;34(3):451–460. doi: 10.1038/s41433-019-0566-0.
   PubMed Web of Science ®Google Scholar